Literature DB >> 6371540

Biochemical variation of Cryptococcus neoformans.

K A Schmeding, S C Jong, R Hugh.   

Abstract

Ninety-seven strains of Cryptococcus neoformans and C. bacillisporus were examined for 44 biochemical characters and the results were analyzed numerically. One phenon emerged at the 86% level of similarity when strains were clustered according to their M-similarity values. All strains grew in ten carbon sources (D-glucose, D-galactose, arbutin, maltose, sucrose, D-melezitose, D-xylose, D-mannitol, D-glucitol, and meso-inositol), and also grew at 37 degrees C and produced urease and phenoloxidase. None of them grew in melibiose, lactose, nor valine, and none reduced nitrate to nitrite. Comparison of selected biochemical characters, creatinine utilization, and serotypes of 49 aberrant strains is presented. Forty-eight of the 97 strains produced the Filobasidiella state either alone or when paired with a strain of compatible mating-type. Filobasidiella neoformans serotypes A and D were interfertile with compatible mating-types of F. bacillispora serotypes B and C. The 44 biochemical characters and 4 serotypes did not predict barriers to mating competence. The present study further substantiates that Filobasidiella neoformans and F. bacillispora are one species.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371540     DOI: 10.1007/bf00436523

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  22 in total

1.  Rapid method for determining nitrate utilization by yeasts.

Authors:  J M Hopkins; G A Land
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

2.  Comparative taxonomy of the genus Torulopsis Berlese.

Authors: 
Journal:  J Gen Microbiol       Date:  1973-12

3.  Serologic grouping of Cryptococcus neoformans.

Authors:  D E Wilson; J E Bennett; J W Bailey
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

4.  Distribution and epidemiologic significance of the serotypes of Cryptococcus neoformans.

Authors:  J E Walter; E G Coffee
Journal:  Am J Epidemiol       Date:  1968-01       Impact factor: 4.897

5.  The indirect fluorescent antibody test for the detection of antibody in human cryptococcal disease.

Authors:  R A Vogel
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

6.  A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes.

Authors:  K J Kwon-Chung
Journal:  Mycologia       Date:  1976 Jul-Aug       Impact factor: 2.696

7.  Uridine diphosphate d-xylose. Acceptor xylosyltransferase of Cryptococcus laurentii.

Authors:  A Cohen; D S Feingold
Journal:  Biochemistry       Date:  1967-09       Impact factor: 3.162

8.  Caffeic acid-containing medium for identification of Cryptococcus neoformans.

Authors:  R L Hopfer; F Blank
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

9.  Biochemical differences between serotypes of Cryptococcus neoformans.

Authors:  J E Bennett; K J Kwon-Chung; T S Theodore
Journal:  Sabouraudia       Date:  1978-09

10.  Capsular reactions and soluble antigens of Torula histolytica and of Sporotrichum schenckii.

Authors:  J M NEILL; C G CASTILLO
Journal:  J Exp Med       Date:  1949-01       Impact factor: 14.307

View more
  3 in total

1.  Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type.

Authors:  B L Wickes; M E Mayorga; U Edman; J C Edman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates.

Authors:  Kirsten Nielsen; Gary M Cox; Ping Wang; Dena L Toffaletti; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Serotypes and mating types of clinical strains of Cryptococcus neoformans isolated in Taiwan.

Authors:  M M Hsu; J C Chang; K Yokoyama; K Nishimura; M Miyaji
Journal:  Mycopathologia       Date:  1994-02       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.